BACKGROUND Screening for subclinical TDP43 neuropathology in autoimmune conditions: a pilot study Natasha Clarke, Nidhi Sofat, Lena Assi and Peter GarrardContact:

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

Frontotemporal Dementia
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
Journal Club Alcohol and Health: Current Evidence November-December 2005.
Pragmatic Randomised Trials. Background Many clinical trials take place in artificial conditions that do not represent NORMAL clinical practice. Often.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Mild Cognitive Impairment
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
A 67-year-old male with behavioral and language problems
INTRODUCTION Mutations in Presenilin (PS) 1 and 2 cause familial Alzheimer’s Disease (AD) through undetermined mechanisms. PS’s are intramembranous aspartyl.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Dementia Research Group MRI, rates of atrophy and Alzheimer’s disease Nick Fox Dementia Research Group Institute of Neurology, UCL Queen Square, London.
Attention Deficit Hyperactivity Disorder (ADHD) Student Classification Using Genetic Algorithm and Artificial Neural Network S. Yenaeng 1, S. Saelee 2.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.
Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders Robert S. Katz 1, Frederick Wolfe 2. 1 Rush University Med Center,
The Argument for Using Statistics Weighing the Evidence Statistical Inference: An Overview Applying Statistical Inference: An Example Going Beyond Testing.
METABOLIC SYNDROME, NEUROINFLAMMATION AND COGNITIVE IMPAIRMENT: STATE OF THE ART AND DATA FROM A SECOND LEVEL OUTPATIENT CLINIC IN ITALY Valeria Calsolaro.
Procedures Manual, Control Series, & Phenotype Committee Update Stephanie Doan, MPH NIA AD Genetics Initiative Co-Coordinator Columbia University.
Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusions, behavioural symptoms, quality of life and caregiver effects in.
2010 MEETING, PHILADELPHIA AMERICAN ASSOCIATION OF NEUROPATHOLOGISTS DSS CASE # 11 J-M BILBAO, B YOUNG and N LIU SUNNYBROOK HOSPITAL UNIVERSITY OF TORONTO.
The Effect of ApoE Genotype, Plasmalogen Biosynthesis, and Reverse Cholesterol Transport Biomarkers on Cognition and Odds of Alzheimer’s Disease in Elderly.
CU-1 Summary of Neuropathological and Clinical Features of PDD Clive Ballard, MD Professor of Age Related Diseases Institute of Psychiatry King’s College.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Under the supervision of miklós jászberényi
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
OUTCOME MEASURES IN PsA: IMMUNOHISTOLOGY Oliver FitzGerald.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
ARTHRITIS Rheumatoid Arthritis Presented By: Ali Raza Ansar Qudsia Sehar Hafsa Kabir Rheumatoid Arthritis Presented By: Ali Raza Ansar Qudsia Sehar Hafsa.
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Biomedical Research Centre for Mental Health and Dementia Unit at South London and Maudsley NHS Foundation Trust the Institute of Psychiatry, King’s College.
AFTD Education Conference Research Update: Focus on Two Large Federally Funded Projects: LEFFTDS and ARTFL David Knopman MD Neurology Mayo Clinic Rochester.
Frontotemporal Lobar Degeneration:
Association of Body Mass Index (BMI) and Depression Severity
C-Reactive Protein & Cognitive Function
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
Value of cerebrospinal fluid visinin-like protein-1 (VILIP-1) for prediction of mild cognitive impairment progression to Alzheimer's disease  Mirjana Babić.
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
C.Calia 1, L. Destino2, A. Semeraro 2, M. Pennelli 2, M. F. De Caro 2
Dementia-Related Epilepsy in Vascular Dementia and Alzheimer’s Disease
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Jen Yates, Linda Clare, Bob Woods and CFAS Wales
Results for all features Results for the reduced set of features
A Sporadic Case of Progressive Non-Fluent Aphasia
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Bowden, Shores, & Mathias (2006): Failure to Replicate or Just Failure to Notice. Does Effort Still Account for More Variance in Neuropsychological Test.
Ying Cheng (1st-year PhD), supervised by Dr Gayle Doherty
Frontotemporal dementia syndromes are united by underlying frontotemporal lobar degeneration pathology, which can be divided according to the presence.
Presenter : Dr Aneelraj Co investigators : Dr Srikala Bharath
Imaging AD Progression Amyloid Imaging Agents.
Evaluating classifiers for disease gene discovery
Dermatomyositis perifascicular pattern of involvement
Frontotemporal Dementia
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Reasoning in Psychology Using Statistics
Boston Naming Test predicts deterioration of cerebrospinal fluid biomarkers in pre-symptomatic Alzheimer’s disease Charleen Wilder, MA, Kristina Moncrieffe,
Transmissible human proteopathies: an expanding field
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease  W. Robert Bell, Yang An,
Statistically-Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile AnalysiS.
Figure 1 NMF in ADD patients and classification of prodromal Alzheimer’s disease participants. Grey matter ... Figure 1 NMF in ADD patients and classification.
Evaluating questionnaires
Presentation transcript:

BACKGROUND Screening for subclinical TDP43 neuropathology in autoimmune conditions: a pilot study Natasha Clarke, Nidhi Sofat, Lena Assi and Peter GarrardContact: HYPOTHESIS RESULTS Participants Graded Naming Test Max. possible 30/30 NC mean = 20.4 (SD=4.1) Pyramids and Palm Trees Test Max. possible 52/52 NC mean = 90% Category and letter fluency Letter responses > category responses suggests semantic impairment Figure 3 The three tests included in the semantic battery. “What is this?” “Which of the two bottom pictures goes with the top one?” “Tell me all the animals you can think of, starting now.” Pathology of Frontotemporal Lobar Degeneration TDP-43 Proteinopathy and Inflammation Picture Naming Fluency Semantic Association FTLD-tau Aggregates of tau protein in the form of tufted astrocytes or intracellular aggregates (‘Pick bodies’). See below for histopathology. Presenting clinical syndrome partially predicts underlying pathology: Conclusions  TDP-43 pathology is linked to mutations in the gene coding for the progranulin protein (PGRN), a precursor to the granulin (GRN) family of glycosylated peptides (Tang et al., Science 2011).  FTD GWAS showed significant association at the HLA locus on chromosome 6p21.3 (Ferrar et al., Lancet 2014).  Granulins are involved in cytokine regulation by virtue of their inhibitory effects on TNFα.  Up to 43% of patients with autoimmune conditions such as rheumatoid arthritis (RA), but less than 1% of controls have antibodies against PGRN (Thurner et al., Journal of Autoimmunity 2013).  There is a significantly higher prevalence of autoimmune conditions in patients with definite (GRN mutation positive) or highly probable (clinical diagnosis of SD) TDP-43 pathology than in matched controls with other dementia subtypes (Miller et al., Journal of Neurology, Neurosurgery & Psychiatry 2014). If autoimmune disease and TDP-43 proteinopathy are linked by the presence of circulating antibodies resulting in lower levels of GRN and upregulation of TNFα, we might also expect to see evidence for FTLD-TDP in patients with autoimmune conditions. METHOD Figure 2. Hypothetical mechanistic model. FTLD-TDP Cellular inclusions are positive for both ubiquitin and transactive response DNA- binding protein with 43 kDa (TDP-43). See below for histopathology. 1) Semantic test battery 2) Machine learning classification  40 participants, aged within the usual range of clinical presentation of SD (i.e ) and with English as a first language were recruited via NHS clinics.  All were undergoing treatment for an autoimmune mediated condition (Rheumatoid Arthritis or Psoriatic Arthritis) or had similar systemic symptoms without an autoimmune mechanism (Osteoarthritis).  Participants completed a cognitive screening questionnaire, the Mini Mental State Examination (MMSE), an abbreviated semantic test battery (see below).  A blood sample was obtained for later measurement of progranulin and TNFα. Scores were first transformed in to nominal variables based on a median split, before classification using the J48 classifier (Weka (v3.6)). Decision Tree Accuracy Correctly Classified Instances = 70% Incorrectly Classified Instances = 30% Confusion Matrix ab  Classified as 231a=Inflammatory 115b=Osteoarthritis Graded Naming Test Pyramids & Palm Trees Fluency RatioFluency Studies have consistently shown SD to be underpinned by FTLD-TDP pathology, in up to 90% of cases at post-mortem (e.g. Snowden et al., Acta Neuropathologica 2007);. The presence of a semantic deficit in a patient with FTLD is therefore a clinical biomarker for TDP-43 proteinopathy.  Whilst the current sample size may be too small to support definitive conclusions, this pilot study so far suggests that no single neuropsychological measure is sufficient to reveal underlying TDP43 pathology in this patient population.  Machine learning may provide a possible approach to classifying group membership using a combination of neuropsychological features: the unexpected association between high scores on the GNT and inflammatory disease may reflect a more generally semantically impaired subgroup.  Measurement of progranulin and TNFα levels is currently in progress, and will allow us to look for an association between cognitive and biological markers. Figure 1. Underlying pathology in 71 cases. AD = Alzheimer’s Disease, DLDH = Dementia lacking distinctive histology (Alladi et al., Brain 2007). Figure 6. Boxplot with whiskers from minimum to maximum. Figure 4. Bar graph with error bars showing +/- 1 SD from the mean. Figure 7. Boxplot with whiskers from minimum to maximum. Figure 5. Boxplot with whiskers from minimum to maximum. n.s. p =.15 n.s. p =.13 n.s. p =.46 n.s. p =.31 n.s. p =.84 St George’s, University of London, Cranmer Terrace, London Impaired Semantics Normal Semantics